Clinical trial
Effects on Colesevelam HC1 (WelChol®) on Insulin Sensitivity in Subjects With…
NCT00361153 · Daiichi Sankyo, Industry · Completed
Key facts
| NCT number | NCT00361153 |
|---|---|
| Title | Effects on Colesevelam HC1 (WelChol®) on Insulin Sensitivity in Subjects With Type 2 Diabetes Mellitus |
| Official title | Effects on Colesevelam HC1 (WelChol®) on Insulin Sensitivity in Subjects With Type 2 Diabetes Mellitus |
| Lead sponsor | Daiichi Sankyo, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Type 2 Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | Colesevelam hydrochloride, placebo |
| Enrollment | 35 |
| Start date | May 1, 2006 |
| Primary completion | Oct 1, 2006 |
| Completion | Mar 1, 2007 |
| First posted | Aug 7, 2006 |
| Last update posted | Jun 25, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: